You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Salmeterol Xinafoate

Showing 1 - 25 of 371
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Bioequivalence Trial in Larissa (Fluticasone propionate 500 mcg and salmeterol xinafoate 50 mcg/Respirent Pharmaceuticals,

Recruiting
  • Bioequivalence
  • Fluticasone propionate 500 mcg and salmeterol xinafoate 50 mcg/Respirent Pharmaceuticals
  • ADVAIR DISKUS® 500/50
  • Larissa, Thessaly, Greece
    BECRO Clinical Facility
Aug 29, 2023

Bioequivalence Trial in Larissa (Fluticasone propionate 250 mcg and salmeterol xinafoate 50 mcg/Respirent Pharmaceuticals,

Recruiting
  • Bioequivalence
  • Fluticasone propionate 250 mcg and salmeterol xinafoate 50 mcg/Respirent Pharmaceuticals
  • ADVAIR DISKUS® 250/50
  • Larissa, Thessaly, Greece
    BECRO Clinical Facility
Aug 1, 2023

Asthma Trial (QVM149, Salmeterol Xinafoate / Fluticasone Propionate, Placebo to QVM149)

Not yet recruiting
  • Asthma
  • (no location specified)
Mar 18, 2023

Bioequivalence Trial (Fluticasone propionate 1000 mcg and salmeterol xinafoate 50 mcg/Respirent Pharmaceuticals, ADVAIR DISKUS

Not yet recruiting
  • Bioequivalence
  • Fluticasone propionate 1000 mcg and salmeterol xinafoate 50 mcg/Respirent Pharmaceuticals
  • ADVAIR DISKUS 100/50
  • (no location specified)
Jan 20, 2023

Bioequivalence, Asthma Trial in Larissa (Test, Reference)

Active, not recruiting
  • Bioequivalence
  • Asthma
  • Larissa, Thessaly, Greece
    BECRO Clinical Facility
Oct 19, 2021

Bioequivalence, Asthma Trial in Larissa (Test, Reference)

Active, not recruiting
  • Bioequivalence
  • Asthma
  • Larissa, Thessaly, Greece
    BECRO Clinical Facility
Apr 18, 2021

Bioequivalence Trial in Larissa (Fluticasone propionate 500 mcg and salmeterol xinafoate 50 mcg/Respirent, ADVAIR DISKUS®

Completed
  • Bioequivalence
  • Fluticasone propionate 500 mcg and salmeterol xinafoate 50 mcg/Respirent
  • ADVAIR DISKUS® 500/50
  • Larissa, Thessaly, Greece
    BECRO Clinical Facility
Mar 8, 2021

Bioequivalence Trial in Larissa (Test Product, Reference Product)

Completed
  • Bioequivalence
  • Test Product
  • Reference Product
  • Larissa, Thessaly, Greece
    BECRO Clinical Facility
Mar 8, 2021

Bioequivalence Trial in Larissa (Fluticasone propionate 500 mcg and salmeterol xinafoate 50 mcg/Respirent, ADVAIR DISKUS®

Completed
  • Bioequivalence
  • Fluticasone propionate 500 mcg and salmeterol xinafoate 50 mcg/Respirent
  • ADVAIR DISKUS® 500/50
  • Larissa, Thessaly, Greece
    BECRO Clinical Facility
Jan 18, 2021

Bioequivalence Trial in Larissa (Fluticasone propionate 250 mcg and salmeterol xinafoate 50 mcg/Respirent, ADVAIR DISKUS®

Completed
  • Bioequivalence
  • Fluticasone propionate 250 mcg and salmeterol xinafoate 50 mcg/Respirent
  • ADVAIR DISKUS® 250/50
  • Larissa, Thessaly, Greece
    BECRO Clinical Facility
Jan 18, 2021

Pooled Analysis FP_SX_250_50

Completed
  • Asthma
  • Larissa, Thessaly, Greece
    BECRO Clinical Facility
Mar 5, 2021

Asthma, Allergic Trial in Guangzhou, Wenzhou (CMAB007, Symbicort, Seretide)

Completed
  • Asthma, Allergic
  • Guangzhou, Guangdong, China
  • +1 more
Oct 8, 2021

Bioequivalence Trial in Larissa (Test Product (Fluticasone propionate and salmeterol xinafoate inhalation powder/Respirent

Completed
  • Bioequivalence
  • Test Product (Fluticasone propionate and salmeterol xinafoate inhalation powder/Respirent Pharmaceuticals)
  • +2 more
  • Larissa, Thessaly, Greece
    BECRO Clinical Facility
Jul 5, 2020

Asthma Trial in London (Salmeterol Xinafoate, Salmeterol Fluticasone)

Unknown status
  • Asthma
  • Salmeterol Xinafoate
  • Salmeterol Fluticasone
  • London, United Kingdom
    St Mary's Hospital, Imperial College Healthcare NHS Trust
Aug 4, 2020

Asthma Trial in Las Vegas (Fluticasone propionate/salmeterol, Advair Diskus, 100 Mcg-50 Mcg Inhalation Powder, Placebo)

Completed
  • Asthma
  • Fluticasone propionate/salmeterol
  • +2 more
  • Las Vegas, Nevada
    West-Ward Research Site #1
Nov 26, 2019

Persistent Asthma Trial in United States (Fp MDPI, FS MDPI, FLOVENT HFA)

Completed
Has Results
  • Persistent Asthma
  • Fp MDPI
  • +4 more
  • Birmingham, Alabama
  • +100 more
Nov 6, 2021

Healthy Volunteers Trial in Barcelona (Salmeterol Xinafoate)

Completed
  • Healthy Volunteers
  • Salmeterol Xinafoate
  • Barcelona, Spain
    IMIM (Hospital del Mar Medical Research Institute)
Dec 10, 2019

Bioequivalence Trial in Larissa (Test Product, Reference Product)

Completed
  • Bioequivalence
  • Test Product
  • Reference Product
  • Larissa, Thessaly, Greece
    BECRO Clinical Facility
Sep 9, 2019

Altitude Edema Trial (Advair HFA, Placebo)

Not yet recruiting
  • Altitude Edema
  • Advair HFA
  • Placebo
  • (no location specified)
Sep 8, 2023

Examining Link Between Obesity, Inflammation, and Response to

Completed
  • Asthma
  • Obesity
  • Beclomethasone dipropionate HFA
  • +2 more
  • San Diego, California
  • +9 more
Oct 19, 2020

Asthma Trial in Athens (Fluticasone Propionate 100 mcg and Salmeterol 50 mcg inhalation Powder/Respirent Pharmaceuticals, ADVAIR

Not yet recruiting
  • Asthma
  • Fluticasone Propionate 100 mcg and Salmeterol 50 mcg inhalation Powder/Respirent Pharmaceuticals
  • +2 more
  • Athens, Greece
    BECRO Ltd.
Jan 20, 2023

Bronchial Asthma Trial in Poland, Ukraine (beclomethasone dipropionate plus formoterol fumarate combination, fluticasone

Completed
  • Bronchial Asthma
  • beclomethasone dipropionate plus formoterol fumarate combination
  • fluticasone propionate plus salmeterol xinafoate combination
  • Gdansk, Poland
  • +11 more
Jul 30, 2020

Asthma Trial in Worldwide (FS MDPI, Fp MDPI, Placebo MDPI)

Completed
Has Results
  • Asthma
  • FS MDPI
  • +3 more
  • Birmingham, Alabama
  • +153 more
Nov 5, 2021

Asthma Trial in Hackensack, New York (Fluticasone with salmeterol, Fluticasone HFA)

Completed
  • Asthma
  • Fluticasone with salmeterol
  • +3 more
  • Hackensack, New Jersey
  • +2 more
Oct 12, 2022

Asthma Trial in United States (MGR001 (Fixed dose combination of Fluticasone propionate and salmeterol xinafoate), Advair (Fixed

Completed
Has Results
  • Asthma
  • MGR001 (Fixed dose combination of Fluticasone propionate and salmeterol xinafoate)
  • +2 more
  • Birmingham, Alabama
  • +100 more
Feb 22, 2022